Kalytera Therapeutics Inc (OTCMKTS:KALTF)’s stock price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.03 and traded as high as $0.03. Kalytera Therapeutics shares last traded at $0.03, with a volume of 42,275 shares.
The stock’s 50-day moving average price is $0.03 and its 200-day moving average price is $0.03.
About Kalytera Therapeutics (OTCMKTS:KALTF)
Kalytera Therapeutics, Inc, a clinical-stage specialty pharmaceutical company, develops cannabinoid medicines for a range of unmet medical needs. It is developing cannabidiol formulations to prevent and treat acute graft versus host diseases. The company is also developing K-1032, a prodrug for the treatment of chronic inflammatory skin diseases, such as acne vulgaris; K-1012, a prodrug for the treatment of adult respiratory distress syndrome; K-1022, a prodrug to treat ulcerative colitis; and K-1052, a prodrug for the treatment of sepsis-induced acute renal failure and traumatic brain injury.
Featured Article: Bid-Ask Spread
Receive News & Ratings for Kalytera Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kalytera Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.